Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:Prephenic acid)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteUnits(range)
ST003104 AN005083 Metabolomics studies on human cardiac samples Heart Human Heart disease University of Sydney abundance
ST003252 AN005328 Metabolomics studies on mouse cardiac samples on a Western diet Heart Mouse Obesity; Diabetes; Hypertension; Hyperglycemia University of Sydney abundance
ST003253 AN005331 Metabolomics studies on mouse liver samples on a Western diet Liver Mouse Obesity; Diabetes; Hypertension; Hyperglycemia University of Sydney abundance
ST002316 AN003783 Differential requirements for mitochondrial electron transport chain components in the adult murine liver - Untargeted Metabolomics (qTOF) Liver Mouse Metabolic syndrome The University of Texas Southwestern Medical Center at Dallas area
ST002234 AN003644 A metabolic map of the DNA damage response identifies PRDX1 in nuclear ROS scavenging and aspartate synthesis Cultured cells Human DNA damage response CRG au
ST002123 AN003476 GCN2 regulates mitochondrial OXPHOS in HSPCs under proliferation conditions. Bone marrow Mouse Sun Yat-sen University AU
ST002373 AN003868 Extracellular metabolome of activated CD8+ T cells Cultured cells Mouse Johns Hopkins University AUC
ST001980 AN003230 Metabolomic profiles in S. mutans, S. gordonii, and S. oralis cells treated with D-tagatose Bacterial cells Streptococcus Osaka University intensity
ST000148 AN000235 A549 13C-labeled Cell Study Epithelial cells Human Cancer University of Kentucky normalized corrected peak area
ST002011 AN003279 The anticancer human mTOR inhibitor MLN0128/Sapanisertib with potent multistage in vitro antiplasmodium activity and in vivo antimalarial efficacy in a humanised mouse model is an inhibitor of multiple Plasmodium falciparum kinases. Blood Plasmodium falciparum Malaria Pennsylvania State University peak area
ST002078 AN003389 Multiple modes of interfering with the activity of Plasmodium falciparum cytoplasmic isoleucyl-tRNA synthetase illustrate the enzyme is a promising antimalarial target. Cultured cells Plasmodium falciparum Malaria Pennsylvania State University peak area
ST000142 AN000225 H1299 13C-labeled Cell Study Lung Human Cancer University of Kentucky Peak area
ST001232 AN002050 Combining stage - specificity and metabolomic profiling to advance drug discovery for malaria Cultured cells Plasmodium falciparum Malaria Pennsylvania State University Peak area
ST001382 AN002303 Distinct metabolic states of a cell guide alternate fates of mutational buffering through altered proteostasis Bacterial cells E. coli CSIR National Chemical Laboratory Peak intensity
ST002541 AN004187 Methionine restriction constrains lipoylation and activates mitochondria for nitrogenic synthesis of amino acids (Part 1) Yeast cells Yeast Life Sciences Institute, ZheJiang University Peak intensity
ST002542 AN004189 Methionine restriction constrains lipoylation and activates mitochondria for nitrogenic synthesis of amino acids (Part 2) Yeast cells Yeast Life Sciences Institute, ZheJiang University Peak intensity
ST001299 AN002163 Metatranscriptomic Analysis of the Mouse Gut Microbiome Response to the Persistent Organic Pollutant 2,3,7,8-Tetrachlorodibenzofuran Intestine Mouse The Pennsylvania State University (Penn State) ppm
ST002082 AN003397 Predicting dying: a study of the metabolic changes and the dying process in patients with lung cancer Urine Human Cancer University of Liverpool Institute of Life Course & Medical Sciences Values are raw peak area
  logo